Synthesis and pharmacological properties of 4(5)-(2-ethyl-2,3-dihydro-2 silainden-2-yl)imidazole, a silicon analogue of atipamezole

4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available α 2-adrenergic receptor antagonist atipamezole 1, were prepared a...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 31; no. 9; pp. 725 - 729
Main Authors Heinonen, P, Sipilä, H, Neuvonen, K, Lönnberg, H, Cockcroft, VB, Wurster, S, Virtanen, R, Savola, MKT, Salonen, JS, Savola, JM
Format Journal Article
LanguageEnglish
Published PARIS CEDEX 15 Elsevier Masson SAS 1996
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:4(5)-(2-Ethyl-2,3-dihydro-2-silainden-2-yl)imidazole 2a, 4(5)-(2-methyl-2,3-dihydro-2-silainden-2-yl)imidazole 2b and 4(5)-(2-ethyl-2,3-dihydro-2-silainden-2-yl)-2-methylimidazole 2c, C2 silicon analogues of the commercially available α 2-adrenergic receptor antagonist atipamezole 1, were prepared and their pharmacological properties were evaluated. The results show that 2a retained significant affinity for the receptors, and the in vivo pharmacokinetic properties of 2a were comparable to those of 1.
ISSN:0223-5234
1768-3254
DOI:10.1016/0223-5234(96)85882-X